FY251 results ahead of market expectations2: revenue up c.24% and adjusted EBITDA3 up c.19% year-on-year
Applied Nutrition plc, a leading sports nutrition, health and wellness brand, today announces an update on trading for the financial year ending 31 July 20251 and outlook for the financial year ending 31 July 20264.
FY251 Trading Update
Driven by strong second-half trading (approximately £60m of revenue), Group revenue is expected to be ahead of market expectations2, with revenue up 24% year-on-year to approximately £107 million (FY24: £86 million) and adjusted EBITDA3 up approximately 19% year-on-year (FY24: £26m). Net cash (excluding IFRS 16 liabilities) at the end of period is also expected to be ahead of market expectations2 at approximately £18.5 million.
The results for FY25 were achieved by the continued delivery of the Group’s multi-pillar, global growth strategy.
FY26 Outlook4
Following the strong recent trading and supported by the strategic progress, the Group now expects revenue for the financial year ending 31 July 2026 to be ahead of current market expectations (2).
The Board remains confident that the Group’s core strengths, including its B2B-focused business model, breadth of high-quality products and industry leading new product development, will continue to drive sustained revenue growth and strong profitability over the long-term.
Notice of Results
The Group expects to release its results for the year ended 31 July 2025 on, or around, 10 November 2025.
Thomas Ryder, CEO of Applied Nutrition, said:
“We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations. Our focus and ambition remain as strong as ever – in delivering for our shareholders, customers and team – and we are excited about the opportunities we have in the pipeline for the year ahead.”
Notes:
1: All figures used in this announcement relating to FY25 remain subject to audit.
2: Consensus market expectations for FY25 and FY26 before today were:
| Measure | FY25 | FY26 |
| Revenue | £100.0 million | £112.4 million |
| Net cash | £16.6 million | £31.5 million |
3 Adjusted EBITDA excludes exceptional items. The only exceptional items are expected to relate to the Group’s Initial Public Offering (“IPO”) during FY25.
